BioStem Technologies's market cap is currently $84.31M. The company's EPS TTM is $-0.03; its P/E ratio is 4.52; BioStem Technologies is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
